Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Cardiovascular rehabilitation adapted to transient ischaemic attack and stroke
ISRCTN ISRCTN90272638
ClinicalTrials.gov identifier
Public title Cardiovascular rehabilitation adapted to transient ischaemic attack and stroke
Scientific title A randomised controlled trial to evaluate the benefit of a cardiac rehabilitation programme for improving fitness and reducing cardiovascular risk factors in the non-acute ischaemic stroke and transient ischaemic attack populations
Acronym CRAFTS
Serial number at source HSR/2007/6
Study hypothesis A comprehensive cardiac rehabilitation programme involving aerobic exercise training, brief life-style intervention counselling and two didactic classes in risk reduction effects a greater change in cardiac risk score (as calculated from blood pressure, lipid profile, age, sex and diabetic status) and healthy lifestyle participation (exercise, diet and smoking cessation) than education classes alone.
Lay summary Not provided at time of registration
Ethics approval Ethics approval received from the University of Dublin Human Research Ethics Sub-committee (ref: HREC-19-06-Blake) on the 25th May 2006. This included approval for a qualitative strand currently completed.
Study design A single blinded randomised controlled trial
Countries of recruitment Ireland
Disease/condition/study domain Stroke, transient ischaemic attack
Participants - inclusion criteria 1. Adults of either gender aged greater than 18 years of age who have sustained an ischaemic stroke (confirmed by computed tomography [CT] or magnetic resonance imaging [MRI]) or a transient ischaemic attack (TIA)
2. Cerebrovascular accident [CVA] greater than one year recruited through the community with medical consent
3. CVA less than 1 year with consent of their hospital consultant
4. TIA greater than 3 months with consent of their hospital consultant
Participants - exclusion criteria 1. Major medical conditions
2. Oxygen dependence
3. Unstable cardiac conditions including angina
4. Uncontrolled diabetes
5. Claudication
6. Acute febrile illness
7. Cognitive impairment
8. Pregnancy
9. Uncontrolled diabetes
Anticipated start date 01/10/2007
Anticipated end date 31/10/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 240
Interventions Over 8 weeks:
Control subjects will attend two one-hour educational session addressing risk factor reduction and lifeskills.

Intervention subjects will attend the two educational classes listed above. In addition they will attend for 16 one-hour aerobic training sessions and will receive brief intervention counselling individually tailored to their lifestyle risk factors and readiness to change on the transtheoretical model.
Primary outcome measure(s) 1. Adherence to the European guidelines for cardiovascular disease prevention in a high risk group as evidenced by the % of smokers, fruit and vegetable intake and habitual exercise, i.e. % taking moderate to vigorous activity greater than three times a week extrapolated from the International Physical Activity Questionnaire
2. Cardiac Risk Score

Baseline measures of the primary and secondary outcomes will be taken on week 1. Reassessment will be conducted on week 10 and at a one year interval.
Secondary outcome measure(s) 1. Physical fitness: VO2 as calculated from a steady state sub-maximal cycle ergometry test
2. Health related quality of life as measured by the Stroke Specific Quality of Life Index, Hospital Anxiety and Depression Scale, Functional Health Status COOP/WONCA Scale
3. Economic evaluation derived from EuroQol-5D

Baseline measures of the primary and secondary outcomes will be taken on week 1. Reassessment will be conducted on week 10 and at a one year interval.
Sources of funding 1. Health Research Board (HRB) (Ireland) (ref: HSR/2007/6)
2. University College Dublin (Ireland) (ref: Seed Fund SF109)
Trial website
Publications 1. 2008 pilot study in http://www.ncbi.nlm.nih.gov/pubmed/18212034
2. 2011 results in http://www.ncbi.nlm.nih.gov/pubmed/20813545
Contact name Dr  Catherine  Blake
  Address School of Physiotherapy and Performance Science
Health Sciences Building
University College Dublin
Belfield
  City/town Dublin
  Zip/Postcode 4
  Country Ireland
Sponsor Health Research Board (HRB) (Ireland)
  Address 73 Lower Baggot Street
  City/town Dublin
  Zip/Postcode 2
  Country Ireland
  Sponsor website: http://www.hrb.ie
Date applied 30/07/2008
Last edited 17/01/2012
Date ISRCTN assigned 29/09/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central